Evidence map›Paper›PMID 28204939›Full record

ArticleJournal of molecular modeling2017

Metadynamics combined with auxiliary density functional and density functional tight-binding methods: alanine dipeptide as a case study.

Jerome Cuny, Kseniia Korchagina, Chemseddine Menakbi, Tzonka Mineva

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jerome CunyLaboratoire de Chimie et Physique Quantiques (LCPQ), Université de Toulouse III [UPS] and CNRS, 118 Route de Narbonne, 31062, Toulouse, France.
Kseniia KorchaginaLaboratoire de Chimie et Physique Quantiques (LCPQ), Université de Toulouse III [UPS] and CNRS, 118 Route de Narbonne, 31062, Toulouse, France.
Chemseddine MenakbiUMR 5253 CNRS/ENSCM/UM, MACS, Institut Charles Gerhardt Montpellier, 8 rue de l'Ecole Normale, 34296, Montpellier cedex 5, France.
Tzonka MinevaUMR 5253 CNRS/ENSCM/UM, MACS, Institut Charles Gerhardt Montpellier, 8 rue de l'Ecole Normale, 34296, Montpellier cedex 5, France. tzonka.mineva@enscm.fr.ORCID http://orcid.org/0000-0002-9156-2396

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Application of ab initio molecular dynamics to study free energy surfaces (FES) is still not commonly performed because of the extensive sampling required. Indeed, it generally necessitates computationally costly simulations of more than several hundreds of picoseconds. To achieve such studies, efficient density functional theory (DFT) formalisms, based on various levels of approximate computational schemes, have been developed, and provide a good alternative to commonly used DFT implementations. We report benchmark results on the conformational change FES of alanine dipeptide obtained with auxiliary density functional theory (ADFT) and second- and third-order density functional tight-binding (DFTB) methods coupled to metadynamics simulations. The influence of an explicit water solvent is also studied with DFTB, which was made possible by its lower computational cost compared to ADFT. Simulations lengths of 2.1 and 15 ns were achieved with ADFT and DFTB, respectively, in a reasonably short computational time. ADFT leads to a free energy difference (ΔF

Indexed as

Biophysical PhenomenaThermodynamicsAlanineDipeptidesMolecular Dynamics SimulationQuantum TheorySolventsWaterAlanineDipeptidesSolventsWaterAlanine dipeptideAuxiliary density functional theoryFree energy surfaceMetadynamicsTight-binding density functional theory

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.